- Home
- ETW vs QDEL Comparison
ETW vs QDEL Comparison
Compare ETW & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
ETW
Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Current Price
Company Overview
Basic Information| Metric | ETW | QDEL |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | 2005 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ETW | QDEL |
|---|---|---|
| Price | $9.46 | $11.37 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $28.25 |
| AVG Volume (30 Days) | 238.3K | ★ 3.0M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $8.22 | $9.92 |
| 52 Week High | $9.60 | $35.58 |
Technical Indicators
Market Signals| Indicator | ETW | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 58.40 | 42.11 |
| Support Level | $9.19 | $10.86 |
| Resistance Level | $9.57 | $12.85 |
| Average True Range (ATR) | 0.08 | 0.92 |
| MACD | -0.01 | 0.17 |
| Stochastic Oscillator | 74.00 | 51.88 |
Price Performance
Historical ComparisonAbout ETW Eaton Vance Corporation Eaton Vance Tax-Managed Global Buy-Write Opportunites Fund of Beneficial Interest
Eaton Vance Tax-mangd Glo Buy-write Oppo is a United States-based diversified, closed-end management investment company. The primary investment objective of the company is to provide current income and gains. The secondary objective of the fund is capital appreciation. The fund invests in a diversified portfolio of common stocks and writes call options on one or more U.S. indices on a substantial portion of the value of its common stock portfolio to generate current earnings from the option premium. Its portfolio of investments consists of capital markets, chemicals, banks, biotechnology, media, and other sectors.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.